TCT-18 Feasibility, safety and outcomes of chronic total occlusion revascularization in end-stage renal disease

Yasir Parviz,Matthew Finn,Nisha Jhalani,Bharath Rathakrishnan,Keyvan Karimi Galougahi,Gary S. Mintz,Akiko Maehara,Ajay J. Kirtane,Ori Ben-Yehuda,Gregg W. Stone,Mark A. Hardy,Sumit Mohan,Geoffery Dube,Russell J. Crew,Jai Radhakrishnan,David J. Cohen,Lloyd E. Ratner,Ali Akhund,Ming Liao,Martin B. Leon,Jeffrey W. Moses,Emmanouil S. Brilakis,Dimitri Karmpaliotis,Ziad A. Ali

TCT-18 Feasibility, safety and outcomes of chronic total occlusion revascularization in end-stage renal disease

2017

The feasibility, safety and outcomes of chronic total occlusion (CTO) revascularization in end-stage renal disease (ESRD) are not known. We retrospectively compared patients with (n=40) and without ESRD (n=87) who underwent CTO revascularization with complete 1-year follow-up. The primary endpoint

Keywords:

Revascularization
Disease
Internal medicine
Diabetes mellitus
Cardiology
Occlusion
Medicine
end stage renal disease
Surgery
total occlusion
Clinical endpoint

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations